UCSF

Tagged: UCSF - UC Berkeley Joint Graduate Group in Bioengineering

Novel diabetes treatment developed in Desai Lab to power SF-area startup

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Wired magazine visits The Kidney Project

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products...

Using antibiotics to stop contamination in cell cultures changes them, study finds

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Meet D’Anne Duncan

The newest face on campus is D’Anne Duncan, PhD, who just moved here from Nashville, Tennessee.

Meet BTS Alum Adam Mendelsohn

Adam Mendelsohn, PhD, is co-founder and CEO of Nano Precision Medical, Inc., an Emeryville-based startup company that is developing a rice-grain-sized subdermal implant that delivers medicine at constant rates over time.

Pharmaceutical Chemistry Job Fair

All postdocs and final-year graduate students are invited.

Space is limited to 50. To sign up or for more information, contact Alma Agorilla: [email protected]

Lunch is provided.

Event Highlights


Career panel discussion


Guests from both small and large companies

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

Pages